Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (100.0%)Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B
Phase 3
Suspended
- Conditions
- Influenza
- First Posted Date
- 2009-01-23
- Last Posted Date
- 2009-03-06
- Lead Sponsor
- Nanogen, Inc.
- Target Recruit Count
- 650
- Registration Number
- NCT00828100
- Locations
- 🇺🇸
Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Prospective Evaluation of the Fluid Rapid Influenza Test
Phase 3
Suspended
- Conditions
- Influenza
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2009-04-15
- Lead Sponsor
- Nanogen, Inc.
- Target Recruit Count
- 1300
- Registration Number
- NCT00826709
- Locations
- 🇺🇸
Naval Health Research Center, San Diego, California, United States
🇺🇸University Clinical Research - DeLand, LLC, DeLand, Florida, United States
🇺🇸Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States
Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples
Completed
- Conditions
- Congestive Heart Failure (CHF)
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2008-12-10
- Lead Sponsor
- Nanogen, Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT00734045
- Locations
- 🇺🇸
US Department of Veteran's Affairs, San Diego, California, United States
🇺🇸San Francisco General Hospital, San Francisco, California, United States
News
No news found